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AMINO acids bearing the nitrogen mustard group, i.e. di-(2-chlorethyl)amino-,
have been found to be effective inhibitors ofthe Walker carcinoma in rats (Bergel
and Stock, 1953, cf. Stock, 1958). Furthermore, in the case of one of these
compounds, namely p-di-(2-chlorethyl)aminophenylalanine (Bergel and Stock,
1954) it was found (Bergel and Stock, 1953; Koller and Veronesi, 1956) that the
L-isomer was more active than the D-isomer in various biological systems (Fahmy
and Fahmy, 1956; Elson, 1958). This effect of the configuration of the amino
acid portion of the molecule on the activity suggested that the action of the
L-compound might be influenced by its possible incorporation into proteins.
Cohn (1957) attempted to obtain evidence for this incorporation into protein by
administering p-di-(2-chlorethyl)amino-DL-phenyl[f,-14C]alanine (Bergel, Burnop
and Stock, 1955) to a rat and subsequently isolating the tissue proteins of the
animal. He found that the proteins of the tumour, liver, blood and kidney were
all labelled and that most of the activity was retained after the labelled protein
had been treated with reagents which would be expected to break ester and ether
bonds. However, he also found that liver protein and plasma albumin became
firmly labelled after treatment with the labelled mustard in vitro under conditions
in which no protein synthesis could be expected. Furthermore, similar results
were obtained in vitro using the drug after hydrolysis, which was shown to contain
a complex mixture of degradation products and not only p-di-(2-hydroxyethyl)-
amino-DL-phenyl[f_-14C]alanine.
In view of the complicated and inconclusive nature of these results it was
thought worthwhile to synthesize p-di-(2-hydroxy[l4C2]ethyl)amino-L-phenyl-
alanine and examine its behaviour. This compound having no reactive chloro-
groups would not appear to be capable of reacting with intact proteins via these
groups and therefore its presence in proteins in a firmly bound form could be
taken as evidence of incorporation through peptide bond formation.
EXPERIMENTAL
[14C2]Ethylene oxide was prepared from barium carbonate essentially by the
method of Cox and Warne (1951) except that the labelled ethylene was reacted
with N-bromoacetamide to produce ethylene bromohydrin (Waltz, Fields and
Gibbs, 1951) which was then converted to [14C2]ethylene oxide.
Reaction of [14C2]Ethylene oxide with Ethyl-p-amino-Na-phthaloyl-L-phenyl-
alaninate (Bergel and Stock, 1954). Ethyl-p-amino-N-phthaloyl-L-phenylalanin-
ate (86-5 mg.) was dissolved in 75 per cent acetic acid (0.7 c.c.) and introduced into
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a thick walled glass tube which was constricted so that when later sealed off
at this point the volume within the tube was approximately 3 c.c. The tube was
attached to a high vacuum line cooled in liquid nitrogen and evacuated. [14C2]-
Ethylene oxide (23.5 mg.) previously measured and kept frozen in liquid nitrogen
was released into the vacuum line and condensed into the tube containing the
amine in acetic acid. The reaction tube was sealed off in vacuo and allowed to
warm to room temperature, and then heated at 17000 for 40 hours. The tube
was allowed to cool, opened and the contents transferred to a flask and concen-
trated to dryness, yield pale yellow gum, 130 mg. This product was refluxed
with 6N hydrochloric acid (3 c.c.) for 5 hours. On cooling phthalic acid separated
as a crystalline solid, and was filtered and washed with 6N acid. The filtrate and
washings were concentrated to dryness, water added and again concentrated.
This last step was repeated twice more to remove all traces of hydrochloric acid,
before dissolving in methanol and concentrating to dryness. The resulting
product was a deliquescent brown solid, which was examined by paper chromato-
graphy (descending) using Whatman No. 4 paper and the solvent, n-butanol:
propanol: 0.1 N ammonia in the proportions of 2: 1: 1, clarified if necessary
with propanol. The substances were located on the paper by dipping in a 0.4
per cent solution of ninhydrin in chloroform containing 2.0 per cent acetic acid.
The reaction product was found to contain three ninhydrin positive com-
pounds of Rf 0.14 (brown colour), 0.23 (purple) and 0.29 (purple). The slowest
running substance giving the atypical ninhydrin colour was shown to bep-amino-
L-phenylalanine by comparison of its behaviour on paper chromotography with
that of an authentic specimen. Similarly the compound of Rf 0.29 was shown
to be p-di-(2-hydroxyethyl)amino-L-phenylalanine. An authentic sample of
p-mono-(2-hydroxyethyl)-amino-L-phenylalanine was not available but the general
behaviour of the compound of Rf 0.23 suggested that it was this compound.
A cellulose column (55 x 3.5 cm.) was prepared using Whatman standard
grade cellulose powder and the solvent mixture used for paper chromatography.
The solid obtained from the reaction described above was dissolved in 5 c.c.
ofthe same solvent and applied to the column. When this had been absorbed on
the column, development was continued with the same solvent mixture; 25 c.c.
fractions were collected automatically and were examined by drying down 0.1
c.c. samples on 1 sq. cm. polythene planchet. The counting was carried out
using a mica end-window Geiger-Muller counter connected to a scaling unit.
Under these conditions there was zero self-absorption by the samples. After
counting, the content of the planchets was dissolved in a drop of water, applied
to paper and chromatographed as described above.
It was found that fractions 17 to 20 contained a radioactive product which
was ninhydrin negative. Fractions 24-27 contained p-di-(2-hydroxy[14C2]ethyl)-
amino-L-phenylalanine and fractions 29-32 contained p-mono-(2-hydroxy[14C2]-
ethyl)amino-L-phenylalanine. Fraction 28 contained some of both compounds
so was not used. The p-amino-L-phenylalanine was obtained in fractions 33-35.
The appropriate fractions were bulked and concentrated.
Fractions 24-27 contained only p-di-(2-hydroxy[14C2]ethyl)amino-L-phenyl-
alanine (16 mg.) at a calculated specific activity of 5.4 uc./mg.
Fractions 29-32 contained p-mono-(2-hydroxy[14C2]ethyl)amino-L-phenyl-
alanine (20-5 mg.) at a calculated specific activity of 3.2 /uc./mg. Both these
compounds were obtained as brown solids which could not be crystallized.
314STUDIES ON AMINO ACID INCORPORATION
In vitro experiments
For the in vitro and in vivo experiments thep-di-(2-hydroxy[14C2]ethyl)amino-
L-phenylalanine was used as an aqueous solution at a concentration of 4 mg./c.c.,
i.e. 22 ,tc./c.c.
A. To a solution ofserum albumin (100 mg.) in water (5 c.c.) was added 0.1 ,tc.
of p-di-(2-hydroxy[14C2]ethyl)amino-L-phenylalanine and the mixture incubated
at 37° for 24 hours. The solution was dialysed at 0° overnight and then freeze-
dried. The radioactivity of the resulting protein, as an infinitely thick sample,
was counted in the usual way and was found to be insignificant.
B. A rat liver (9 g.) was homogenized in 0.9 per cent sodium chloride solution
(45 c.c.). To 10 c.c. of this homogenate was added 0.2 ,tc. of p-di-(2-hydroxy-
[14C2]ethyl)amino-L-phenylalanine and the mixture incubated at 37° overnight.
The protein was then isolated in the usual way (Cohn, 1957) and its radioactivity
counted. This activity was found to be insignificant.
In vivo experiments
One Wistar male rat (230 g.) previously starved for 24 hours was injected
intraperitoneally with 13 ,tc. (i.e. 30 ,tc./kg.) of p-di-(2-hydroxy[14C2]ethyl),
amino-L-phenylalanine in aqueous solution (0.6 c.c.). After 75 minutes the animal
was killed (neck broken) and the following tissues removed; (a) Kidney, (b)
Liver, (c) Spleen, (d) Thymus, (e) Blood.
A sample of each of these tissues was treated for the isolation of total protein
as described by Cohn (1957) and the final dry solids were plated on 1 sq. cm. poly-
thene planchets and the radioactivity counted at infinite thickness. In a further
similar experiment, 10 ,c. of the labelled amino acid analogue were injected into
a rat and the tissues of kidney, liver and spleen isolated as before. The result of
these experiments is given in Table I.
TABLE I.-Radioactivity Found in the Protein of Several Tissues of the Rat after
the Administration of p-di-(2-hydroxy[14C2]ethyl)amino-L-phenylalanine
Counts/min.
Infinitely thick sample
on 1 sq. cm. disc
(1 yc./g. = 580 c./m.)
Tissue
examined Experiment 1 Experiment 2
Kidney protein . 9 12
Liver protein . . 3 Nil
Blood protein . . 2
Spleen protein . 2 2
Thymus protein . . Nil
In order to determine what radioactivity might be expected in tissue protein
if the phenylalanine analogue had been incorporated, 10 ,c. of L-[G-14C]phenyl-
alanine was injected into a rat and the tissue proteins isolated as in the previous
experiments. The result obtained is shown in Table II.
DISCUSSION
In the preparation of di-(2-hydroxyethyl)amino compounds by the reaction
of ethylene oxide and an amine, a large excess of ethylene oxide is normally
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TABLE II.-Radioactivity Found in the Protein of Several Tissues of the Rat after
the Administration of L-[G-14C]phenylalanine
Counts/min.
Infinitely thick sample
Tissue on 1 sq. cm. disc
examined (1 ec./g. = 580 c./m.)
Kidney protein . 385
Liver protein . . 485
Spleen protein . 604
used to avoid leaving unchanged amine and mono-(2-hydroxyethyl)amino com-
pounds in the reaction mixture. However, when labelled ethylene oxide is being
used it is obviously uneconomical to use an excess, and so it is to be expected
that a mixture of products will be obtained. Various reaction conditions were
investigated in an attempt to obtain a good yield of the desired p-di-(2-hydroxy-
ethyl)amino-L-phenylalanine, and the method as described in the experimental
section was found most satisfactory.
The in vitro experiments showed clearly that the labelled phenylalanine ana-
logue was not bound to protein under conditions in which Cohn (1957) had found
resulted in firm binding of both p-di-(2-chlorethyl)amino-DL-phenyl[_-14C]-
alanine and of the hydrolysis product of this compound.
The in vivo experiments showed that of the tissue proteins examined only the
protein of kidney showed a level of activity significantly above background and
even in this case the count was extremely low. These results show that p-di-
(2-hydroxy[14C2]ethyl)amino-L-phenylalanine is not incorporated into proteins.
It may therefore be reasonably concluded that the activity which Cohn (1957)
found in tissue proteins, after the injection ofp-di-(2-chlorethyl)amino-DL-phenyl-
[/-14C]alanine is not due to incorporation ofthis compound into protein through
peptide bonds but rather to an alkylation reaction involving the "nitrogen
mustard" portion ofthe molecule. The reason for the greater biological activity
ofthe nitrogen mustard derivative ofL-phenylalanine cannot therefore be ascribed
to such an incorporation. It might be due to a more facile transport of the
L-enantiomorph in comparison with the D-isomer.
SUMMARY
1. The synthesis ofa hydrolysis product ofanL-phenylalanine nitrogen mustard,
namely p-di-(2-hydroxy[14C2]ethyl) amino-L-phenylalanine, from [14C2]ethylene
oxide is described.
2. This compound was found not to react in vitro with serum albumin or the
proteins of rat liver.
3. Injection ofthe compound into rats did not result in any significant labelling
of the tissue proteins.
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